Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
Author:
Publisher
Elsevier
Reference150 articles.
1. Sphingosine kinase 2 and ceramide transport as key targets of the natural Flavonoid Luteolin to induce apoptosis in colon cancer cells;Abdel Hadi;PLoS One,2015
2. Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats;Abdin;European Journal of Pharmacology,2013
3. The selective sphingosine 1-phosphate receptor modulator Etrasimod regulates lymphocyte trafficking and alleviates experimental colitis;Al-Shamma;Journal of Pharmacology and Expimental Therapy,2019
4. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells;An;Cell,2014
5. Novel therapeutic targets for inflammatory bowel disease;Argollo;Journal of Autoimmunity,2017
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polysaccharides of Floccularia luteovirens regulate intestinal immune response, and oxidative stress activity through MAPK/Nrf2/Keap1 signaling pathway in immunosuppressive mice;International Journal of Biological Macromolecules;2024-10
2. Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-09-09
3. DHRS2-induced SPHK1 downregulation contributes to the cell growth inhibition by Trichothecin in colorectal carcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-09
4. 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects;BMC Cancer;2024-08-08
5. A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD;International Immunopharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3